SAM
UTHR icon

Shell Asset Management’s United Therapeutics UTHR Stock Holding History

Shell Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$165K Sell
394
-1,917
-83% -$645K 0.02% 525
2025
Q2 		$664K Sell
2,311
-154
-6% -$46K 0.02% 444
2025
Q1 		$760K Sell
2,465
-101
-4% -$34.6K 0.04% 353
2024
Q4 		$905K Sell
2,566
-2
-0.1% -$735 0.04% 336
2024
Q3 		$920K Buy
+2,568
New +$867K 0.04% 331
2024
Q1 		$1.04M Buy
3,274
+1,354
+71% +$306K 0.05% 292
2023
Q4 		$422K Sell
1,920
-574
-23% -$132K 0.02% 583
2023
Q3 		$563K Sell
2,494
-43
-2% -$9.9K 0.02% 515
2023
Q2 		$560K Sell
2,537
-1,413
-36% -$313K 0.02% 532
2023
Q1 		$885K Sell
3,950
-14
-0.4% -$3.45K 0.04% 390
2022
Q4 		$1.1M Sell
3,964
-825
-17% -$208K 0.05% 348
2022
Q3 		$1M Sell
4,789
-1,255
-21% -$281K 0.04% 365
2022
Q2 		$1.42M Buy
6,044
+11
+0.2% +$2.24K 0.04% 359
2022
Q1 		$1.08M Sell
6,033
-893
-13% -$170K 0.03% 465
2021
Q4 		$1.5M Buy
6,926
+36
+0.5% +$7.07K 0.03% 428
2021
Q3 		$1.27M Sell
6,890
-300
-4% -$59.1K 0.03% 436
2021
Q2 		$1.29M Buy
7,190
+1,105
+18% +$210K 0.03% 463
2021
Q1 		$1.02M Buy
6,085
+1,561
+35% +$260K 0.02% 529
2020
Q4 		$687K Hold
4,524
– – 0.01% 647
2020
Q3 		$457K Buy
4,524
+2,279
+102% +$250K 0.01% 722
2020
Q2 		$272K Buy
+2,245
New +$253K 0.01% 933
2019
Q2 		– Sell
-977
Closed -$115K – 1248
2019
Q1 		$115K Sell
977
-324
-25% -$37.8K ﹤0.01% 1145
2018
Q4 		$142K Sell
1,301
-1,709
-57% -$198K ﹤0.01% 1070
2018
Q3 		$385K Buy
3,010
+952
+46% +$118K 0.01% 1024
2018
Q2 		$233K Hold
2,058
– – ﹤0.01% 1048
2018
Q1 		$231K Sell
2,058
-8,850
-81% -$1.12M ﹤0.01% 1043
2017
Q4 		$1.61M Sell
10,908
-5,269
-33% -$670K 0.03% 459
2017
Q3 		$1.9M Buy
16,177
+429
+3% +$54.8K 0.04% 385
2017
Q2 		$2.04M Sell
15,748
-900
-5% -$112K 0.04% 384
2017
Q1 		$2.25M Sell
16,648
-125
-0.7% -$18.9K 0.05% 345
2016
Q4 		$2.41M Sell
16,773
-4,225
-20% -$539K 0.06% 349
2016
Q3 		$2.48M Sell
20,998
-15,601
-43% -$1.87M 0.05% 354
2016
Q2 		$3.88M Buy
36,599
+1,018
+3% +$114K 0.09% 252
2016
Q1 		$3.96M Buy
35,581
+2,151
+6% +$272K 0.09% 216
2015
Q4 		$5.24M Sell
33,430
-74
-0.2% -$10.8K 0.12% 162
2015
Q3 		$4.31M Buy
33,504
+1,082
+3% +$174K 0.07% 251
2015
Q2 		$5.64M Buy
32,422
+2,446
+8% +$440K 0.11% 196
2015
Q1 		$5.17M Sell
29,976
-3,528
-11% -$538K 0.09% 224
2014
Q4 		$4.34M Hold
33,504
– – 0.07% 270
2014
Q3 		$4.31M Buy
33,504
+3,122
+10% +$322K 0.07% 260
2014
Q2 		$2.69M Sell
30,382
-354
-1% -$34K 0.04% 378
2014
Q1 		$2.89M Sell
30,736
-125
-0.4% -$12.8K 0.05% 356
2013
Q4 		$3.49M Buy
30,861
+4,993
+19% +$450K 0.06% 297
2013
Q3 		$2.04M Hold
25,868
– – 0.04% 478
2013
Q2 		$1.7M Buy
+25,868
New +$1.67M 0.03% 518

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Shell Asset Management's UTHR Position: Q3 2025 in Review

Shell Asset Management reduced its United Therapeutics (UTHR) stake by 83% in Q3 2025, selling an estimated $645K and leaving 394 shares worth $165K. The position accounts for 0.02% of the portfolio, ranked #525.

Shell Asset Management first reported a position in UTHR in Q2 2013 and has held it in 45 quarters since. The position peaked at $5.64M in Q2 2015. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Shell Asset Management held 394 shares of United Therapeutics worth $165K as of Q3 2025.
  • Shell Asset Management sold 1,917 United Therapeutics shares in Q3 2025, an estimated $645K.
  • United Therapeutics made up 0.02% of Shell Asset Management's portfolio in Q3 2025, its #525 holding.
  • Shell Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 45 quarters since.
  • Shell Asset Management's United Therapeutics position peaked at $5.64M in Q2 2015.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.